SBFMW
Sunshine Biopharma Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-2.21
Beta
1.31
52W High
$0.42
52W Low
$0.02
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-16.50%
Forward P/E
—
PEG Ratio
—
About Sunshine Biopharma Inc. Warrant
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.
Fundamentals
| Revenue (TTM) | $35.35M |
| Gross Profit (TTM) | $10.71M |
| EBITDA | $-4.85M |
| Operating Margin | -17.40% |
| Return on Equity | -21.90% |
| Return on Assets | -9.91% |
| Revenue/Share (TTM) | $49.65 |
| Book Value | $43.83 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -1.60% |
| Shares Outstanding | 0 |
| Float | $3.75M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SBFMW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 8/18/2026